343 related articles for article (PubMed ID: 9103392)
1. Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-A.
Bergman CA; Talavera F; Christman GM; Baker VV; Roberts JA; Menon KM
Gynecol Oncol; 1997 Apr; 65(1):63-8. PubMed ID: 9103392
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
[TBL] [Abstract][Full Text] [Related]
3. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM; Providence KM; Higgins PJ
Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta modulation of the epidermal growth factor Ca2+ signal and c-Fos oncoprotein levels in A431 human epidermoid carcinoma cells.
Elliget KA; Phelps PC; Smith MW
Cell Growth Differ; 1996 Apr; 7(4):461-8. PubMed ID: 9052987
[TBL] [Abstract][Full Text] [Related]
5. Regulation of PTP1D mRNA by peptide growth factors in the human endometrial cell line HEC-1-A.
Burke JJ; Talavera F; Menon KM
J Soc Gynecol Investig; 1997; 4(6):310-5. PubMed ID: 9408887
[TBL] [Abstract][Full Text] [Related]
6. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
[TBL] [Abstract][Full Text] [Related]
7. Induction of epidermal growth factor receptor gene transcription by transforming growth factor beta 1: association with loss of protein binding to a negative regulatory element.
Hou X; Johnson AC; Rosner MR
Cell Growth Differ; 1994 Aug; 5(8):801-9. PubMed ID: 7986746
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells.
Subramaniam M; Oursler MJ; Rasmussen K; Riggs BL; Spelsberg TC
J Cell Biochem; 1995 Jan; 57(1):52-61. PubMed ID: 7721958
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells.
Kanatani Y; Kasukabe T; Okabe-Kado J; Hayashi S; Yamamoto-Yamaguchi Y; Motoyoshi K; Nagata N; Honma Y
Cell Growth Differ; 1996 Feb; 7(2):187-96. PubMed ID: 8822202
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of transforming growth factor beta 1 on mitogenic response, transforming growth factor alpha, and c-myc in quiescent, well-differentiated colon carcinoma cells.
Mulder KM; Zhong Q; Choi HG; Humphrey LE; Brattain MG
Cancer Res; 1990 Dec; 50(23):7581-6. PubMed ID: 1701348
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta promotes epidermal growth factor-induced thyroid cell migration and follicle neoformation in collagen gel separable from cell proliferation.
Nilsson M; Dahlman T; Westermark B; Westermark K
Exp Cell Res; 1995 Oct; 220(2):257-65. PubMed ID: 7556432
[TBL] [Abstract][Full Text] [Related]
12. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
Gründker C; Völker P; Schulz KD; Emons G
Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta 1-induced apoptosis in human ovarian carcinoma cells: protection by the antioxidant N-acetylcysteine and bcl-2.
Lafon C; Mathieu C; Guerrin M; Pierre O; Vidal S; Valette A
Cell Growth Differ; 1996 Aug; 7(8):1095-104. PubMed ID: 8853906
[TBL] [Abstract][Full Text] [Related]
14. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW
J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993
[TBL] [Abstract][Full Text] [Related]
15. Growth control and gene expression in a new hepatocellular carcinoma cell line, Hep40: inhibitory actions of vitamin K.
Bouzahzah B; Nishikawa Y; Simon D; Carr BI
J Cell Physiol; 1995 Dec; 165(3):459-67. PubMed ID: 7593224
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
17. The role of C-Fos in growth factor regulation of stromelysin/transin gene expression.
Kerr LD; Magun BE; Matrisian LM
Matrix Suppl; 1992; 1():176-83. PubMed ID: 1480019
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor-induced expression of c-fos is influenced by altered gravity conditions.
de Groot RP; Rijken PJ; Boonstra J; Verkleij AJ; de Laat SW; Kruijer W
Aviat Space Environ Med; 1991 Jan; 62(1):37-40. PubMed ID: 1899994
[TBL] [Abstract][Full Text] [Related]
19. Modulation of epidermal growth factor receptor gene expression by transforming growth factor-beta in a human breast carcinoma cell line.
Fernandez-Pol JA; Klos DJ; Hamilton PD; Talkad VD
Cancer Res; 1987 Aug; 47(16):4260-5. PubMed ID: 3496959
[TBL] [Abstract][Full Text] [Related]
20. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1.
Braun L; Dürst M; Mikumo R; Gruppuso P
Cancer Res; 1990 Nov; 50(22):7324-32. PubMed ID: 2171761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
